We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
187 hedge funds and large institutions have $3.25B invested in Acadia Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 83 increasing their positions, 61 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
36% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 61
4% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 23
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
1% less funds holding
Funds holding: 188 → 187 (-1)
21% less capital invested
Capital invested by funds: $4.11B → $3.25B (-$854M)
43% less call options, than puts
Call options by funds: $24.1M | Put options by funds: $42.3M
Holders
187
Holders Change
-1
Holders Change %
-0.53%
% of All Funds
5.22%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
24
Increased
83
Reduced
61
Closed
23
Calls
$24.1M
Puts
$42.3M
Net Calls
-$18.2M
Net Calls Change
-$22.7M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$52.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$45.9M |
| 3 |
FAM
Fred Alger Management
New York
|
+$35.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.7M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$25.6M |
